Michael Schoen

Department of Dermatology and Venereology, Georg August University Göttingen, Germany

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Dermatology > Skin Cancers (inc. Melanoma & Lymphoma) (since 14 November 2005)

All recent recommendations

• 9.8
  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.
  Recommended by Stefan Martin, Satish Keshav, Michael Schoen
  
• 3.2
  Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
  Recommended by Jeffrey Evans, Michael Schoen
  
• 3.0
  Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides.
  Recommended by Michael Schoen
  
• 4.8
  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
  Recommended by Peter Friedl, Michael Schoen
  
• 3.0
  Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
  Recommended by Michael Schoen
  
• 3.0
  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
  Recommended by Michael Schoen
  
• 3.0
  The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.
  Recommended by Michael Schoen
  
• 3.0
  Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.
  Recommended by Michael Schoen
  
• 3.0
  Localized inflammatory skin disease following inducible ablation of I kappa B kinase 2 in murine epidermis.
  Recommended by Michael Schoen